|Day Low/High||307.64 / 312.86|
|52 Wk Low/High||263.30 / 380.76|
Illumina, Inc. (NASDAQ: ILMN), today announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing, primarily from undisclosed private and strategic investors.
Illumina, Inc. (NASDAQ: ILMN), continuing its strategy to bring the power of genomics into clinical applications, today announced it has named one of the world's top clinical genomics experts to head its clinical genomics...
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of California on behalf...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Illumina, Inc.
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the J.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Illumina, Inc.
Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Jonathan Seaton as Senior Vice President for Corporate & Business Development, further strengthening its executive team as the company continues...
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Illumina, Inc.
Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Illumina, Inc.
HIMX, GG, ABT, ILMN and ENT all were recently downgraded by TheStreet's Quant Ratings.
Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Sam A.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADTN, DOOR, FFKT, FORM, NSH, OBCI, PKX, RGS, SCAI, SPLS, TOL, ZEUS Downgrades: CCE, DTEA, ENT, EVH, ILMN Initiations: FORK Read on to get TheStreet Quant Ratings' detailed report:
Illumina, Inc. (NASDAQ: ILMN) today announced the iHope program, a philanthropic initiative aimed at identifying the genetic causes of undiagnosed rare diseases in children.
Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the company's presentation at the Citi Global Healthcare Conference in New York, NY, on December 7, 2016.
The most recent short interest data has been released for the 10/31/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo's delivery of genetic and genomic...
Illumina, Inc. (NASDAQ:ILMN) today announced the launch of TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the tumor-profiling paradigm from a series of...
Illumina, Inc. (NASDAQ:ILMN) today announced its full financial results for the third quarter of fiscal year 2016.
The Federal Reserve will again convene in the coming week to discuss monetary policy, but investors will instead focus on what it may mean for a rate hike in December.
Gene sequencer Illumina has shaken investors' faith with negative announcements this year.
Illumina, Inc. (NASDAQ: ILMN) and Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), the world's leading healthcare diagnostics company, today announced that on October 5, 2016, the Düsseldorf...
Khang & Khang LLP (the "Firm") announces that it is investigating claims against Illumina Inc.
Levi & Korsinsky announces it has commenced an investigation of Illumina Inc.
Law Offices of Howard G. Smith announces an investigation on behalf of investors of Illumina Inc.
Illumina, Inc. (NASDAQ: ILMN) announced today that it has contributed over 95,000 human genetic variants to ClinVar, a public database hosted by the National Center for Biotechnology Information (NCBI).
Quest and IBM are rolling out a genomic sequencing service powered by Big Blue's Watson supercomputer.
Do that if you like top ticking crowd favorites, but set a protective stop.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.